Established in 2004 as Amgen’s corporate venture capital fund, Amgen Ventures identifies and invests in emerging companies and technologies to advance promising new medicines and solutions to healthcare’s biggest challenges. Globally, Amgen Ventures has strategically invested in human therapeutics and drug discovery efforts that go beyond-the-molecule, such as digital health platforms, data analytics, and value-based approaches.
Learn more at www.amgenbd.com
Baillie Gifford is one of the UK's leading independently owned investment management firms. It is owned and run by 44 of its senior executives who operate as a partnership, a structure which has endured for over a century and which provides stability for clients and motivation for employees. It enables the firm to manage the business for the future as well as the present, with the emphasis on genuine long–term thinking rather than short-term targets.
Brooklands Capital Strategies is a strategic advisor for alternative asset managers and companies seeking to raise capital, connecting investors with the right opportunities to accelerate the development of existing businesses and new ideas.
Canepa Healthcare, LLC is a late-stage venture and growth capital firm specializing in medical device and diagnostic investing.
CLSA is Asia’s leading capital markets and investment group, providing global investors with insights, liquidity and capital to drive their investment strategies. Award-winning research, an extensive Asia footprint, direct links to China, and highly experienced finance professionals differentiate our innovative products and services in alternative investment, asset management, corporate finance, capital markets, and securities and wealth management. Founded in 1986 and headquartered in Hong Kong, CLSA has 1,800 employees globally and operates in 20 cities across Asia, Australia, the Americas and Europe. CLSA is uniquely positioned to facilitate cross-border capital flows and connections between China and the world as a wholly-owned subsidiary of and the international platform of CITIC Securities (SSE: 600030, SEHK: 6030), China’s largest investment bank.
Digital Garage is a Tokyo-based internet company listed on the Tokyo Stock Exchange. The company operates as a business context company through three segments: information technology, marketing technology, and financial technology. Through its global network and coverage, Digital Garage supports promising startup companies all around the world through funding, mentoring, networking, and business management support. The company is a previous investor in Twitter and was responsible for launching and localizing Twitter Japan.
Evidity Health Capital is a late-stage VC and growth equity firm, focused in the U.S. MedTech sector. Evidity invests in medical devices, diagnostics, and digital health leaders in the space. Evidity has been an investor in Akili since its Series A and has participated in all following fundraising rounds.
Fearless Ventures is spreading love through business and capital by investing in companies that are shaping the future of humanity or the planet, and cultivating conscious leadership and win-for-all orientation in those companies.
JAZZ Venture Partners’ investments focus on partnering with visionary entrepreneurs building companies at the intersection of digital technology and neuroscience. JAZZ joined Akili’s Series B and Series C financing rounds.
Ladera Venture Partners (LVP) is a Silicon Valley-based investment firm focused on investments at the convergence of technology and health. LVP is stage-agnostic and highly nimble, focusing on opportunities where the firm's experience, networks and insight can provide meaningful incremental value. Core focus areas include virtual care, mental health, fitness/wellness, and the application of data/AI to the health-related challenges of today and tomorrow.
M Ventures BV is the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany, a leading science and technology company for innovative and top-quality high-tech products in healthcare, life sciences and performance materials. The portfolio includes prescription medications for cancer, multiple sclerosis, and cardiovascular disorders, among many other products.
Mirae Asset is a leading global diversified financial services firm operating out of 30 offices across the Americas, Asia, Europe and the Pacific. Founded in 1997, the company manages over $500bn in investor capital across its asset management, investment banking, life insurance and venture capital businesses. Since its founding, the firm has focused on investing in innovative and breakthrough ideas and teams across all sectors.
Neuberger Berman, founded in 1939, is a private, independent, employee-owned investment manager. The firm manages a range of strategies—including equity, fixed income, quantitative and multi-asset class, private equity, real estate and hedge funds—on behalf of institutions, advisors and individual investors globally. With offices in 25 countries, Neuberger Berman's diverse team has over 2,300 professionals.
NLVP was formed in 2005 when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and six New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry. For more information, visit www.nlvpartners.com.
Omidyar Technology Ventures (OTV) is a Silicon Valley-based venture capital firm created and solely funded by eBay founder, technologist, and philanthropist Pierre Omidyar. OTV looks to partner with founders pursuing big, bold and transformative ideas. The firm invests in early and growth-stage technology companies in enterprise software, AI & big data, consumer services and marketplaces.
Polaris Partners has a 20-plus-year history of partnering with repeat entrepreneurs and world-class
innovators who are improving the way we live and work. The multibillion-dollar firm
manages specialty and diversified funds in healthcare and technology with investments across
all stages. Polaris has offices in Boston, San Francisco, and New York. Learn more at polarispartners.com.
With a commitment to developing innovative medicines that have a potentially superior risk-benefit profile over existing treatment options, PureTech Health aims to address some of the largest health issues facing society today. PureTech Health is a founding shareholder.
Established in 2009, QUAD Investment Management is one of the leading asset management firms in Korea. It believes in the power of expertise, experience, and diversity. Expertise in a given field, coupled by the advantage of experience and diversity in thinking, fuels creativity which leads to innovation. One of the areas it focuses on is healthcare with dedicated investment professionals covering the entire lifecycle from private to public.
Shionogi & Co., Ltd. is global, research driven pharmaceutical company headquartered in Osaka, Japan, that is dedicated to bringing benefits to patients based on its corporate philosophy of “supplying the best possible medicine to protect the health and wellbeing of the patients we serve.” Shionogi’s research and development currently target two therapeutic areas: infectious diseases, and pain/CNS disorders.
Shire is a market-leader in ADHD medications, and has deep experience in ADHD clinical trials. Shire Pharmaceuticals' (SHPG) Strategic Investment group made a direct investment in Akili in 2013. In addition to the monetary investment, Akili and Shire worked closely together to structure and launch Akili's first clinical study of the Project:EVO™ ADHD cognitive measurement product in pediatric ADHD.
Temasek joined Akili’s Series C financing round. Incorporated in 1974, Temasek is an investment company headquartered in Singapore. Temasek's investment strategy allows the company to capture opportunities across the sectors in which they invest that help bring about a better, smarter and more connected world.
